JAN 18, 2017 4:23 PM PST

Malaria Vaccine Developed by Using Genetic Modifications

WRITTEN BY: Carmen Leitch

Malaria has been a global health problem for ages; it comes from a parasite that is over 130 million years old and is referenced as early as 2700 BC.  Researchers may have found some real success in combating the problem at its root, rather than through symptom treatment. A clinical trial using human subjects showed that a new vaccine was safe to use and tolerated by people, and it was effective in inducing the necessary immune response. The work, performed by researchers at the Center for Infectious Disease Research (CIDR) and Fred Hutchinson Cancer Research Center, was reported in Science Translational Medicine. It's discussed in part of the following video, starting at around the second minute.

The researchers utilized a malaria parasite that had been weakened by removing three genes that are required for the pathogenicity of the parasite. The so-called genetically attenuated parasites, GAPs, are unable to reproduce in the human liver. The immune system still builds up an immunity to malaria through the parasite because they remain alive. This is the first use of a genetically attenuated parasite, instead of attenuation by other means, and it has produced success where other methods have failed.

"This most recent publication builds on our previous work," said the GAP project leader, Sebastian Mikolajczak, Ph.D., a CIDR Principal Scientist. "We had already good indicators in preclinical studies that this new 'triple knock-out' GAP (GAP3KO), which has three genes removed, is completely attenuated. The clinical study now shows that the GAP3KO vaccine is completely attenuated in humans and also shows that even after only a single administration, it elicits a robust immune response against the malaria parasite. Together these findings are critical milestones for malaria vaccine development.”

"This report is a major advance in malaria vaccine development by providing the first evidence that genetically attenuated Plasmodium falciparum parasites are safe and immunogenic in humans," commented Robert Seder, M.D., Chief of Cellular Immunology at the Vaccine Research Center of the National Institutes of Health, who was not involved in this work. "Future studies demonstrating protective efficacy will be the next critical milestone for continued development of this promising vaccine approach.”

The GAP3KO project was completed at the CIDR Human Challenge Center,  a part of the Seattle Malaria Clinical Trials Center, an inter-institutional collaboration that works to fight malaria through drug and vaccine development. 

"We are very fortunate to have the human malaria challenge model to take the critical next step evaluating the efficacy of GAP3KO in preventing malaria in people," said Fred Hutch scientist James Kublin, M.D., M.P.H., the Medical Director of the Seattle MCTC. "The Hutch is looking forward to bringing its expertise in clinical trial design and management to the next stage of tests for this vaccine. The collaborations we have with CIDR and other nearby institutions is what makes Seattle a world leader in the malaria vaccine development and the human challenge model."

Malaria causes over 200 million infections, killing almost half a million people in 2015 alone. This new candidate could be a major step forward for regions plagued by the parasite.

 

Sources: AAAS/Eurekalert! via Fearey Group, Malaria.com, Science Translational Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 16, 2020
Clinical & Molecular DX
MAR 16, 2020
New diagnostic tech uses AI to screen blood for over 1400 pathogens
New and reemerging microbial threats continue to challenge the public health and infectious disease response teams world ...
APR 05, 2020
Microbiology
APR 05, 2020
How Life Beneath the Sea Informs the Search for Life on Mars
Single-celled microbes that live beneath the floor of the ocean have provided insight into how scientists might be able ...
MAY 09, 2020
Microbiology
MAY 09, 2020
Mysterious Illness in Children May be Related to COVID-19
Once thought to be mostly unaffected by the virus, rare cases of an inflammatory syndrome are emerging in some kids that ...
MAY 10, 2020
Cell & Molecular Biology
MAY 10, 2020
RNA Structure Informs RNA Function
Proteins carry out many of an organism's critical functions, and they are coded for by genes. To make a protein from ...
MAY 10, 2020
Microbiology
MAY 10, 2020
We Still Don't Know Why Rat Hepatitis is Turning Up in People
Hepatitis is a term for liver inflammation. Hepatitis A, B, C, D, and E are caused by viruses.
MAY 17, 2020
Coronavirus
MAY 17, 2020
Substantial Antiviral Response Seen in Adults Recovered from COVID-19
Some good news comes as researchers scramble for potential vaccine candidates amidst the global COVID-19 pandemic. Scien ...
Loading Comments...